XML 27 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Going Concern and Liquidity
12 Months Ended
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN AND LIQUIDITY

4. GOING CONCERN AND LIQUIDITY

 

U.S. GAAP requires management to assess a company’s ability to continue as a going concern within one year from the financial statement issuance and to provide related note disclosures in certain circumstances.

 

The accompanying consolidated financial statements and notes have been prepared assuming the Company will continue as a going concern. For the year ended December 31, 2021, the Company generated negative cash flows from operations of $39.5 million and had an accumulated deficit of $217.8 million and negative working capital of $3.5 million.

  

Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund growth initiatives. The Company intends to position itself so that it will be able to raise additional funds through the sales of securities in the capital markets, the issuance of debt, and/or by securing lines of credit. The Company completed three public offerings during fiscal year 2021 and received gross proceeds of approximately $45.0 million for the two common stock offerings and $8.0 million for the preferred series offering, before deducting underwriting discounts and commissions and offering expenses.

 

The Company’s fiscal operating results, accumulated deficit and negative working capital, among other factors, raise substantial doubt about the Company’s ability to continue as a going concern. The Company will continue to pursue the actions outlined above, as well as work towards increasing revenue and operating cash flows to meet its future liquidity requirements. However, there can be no assurance that the Company will be successful in any capital-raising efforts that it may undertake, and the failure of the Company to raise additional capital could adversely affect its future operations and viability.